Skip to main content
David A. Wada
( out of 36 reviews )

David A. Wada, MD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2C, Dermatology/Melanoma
1950 Circle of Hope
Salt Lake City , UT 84112

David Wada, MD is a dermatologist who specializes in cutaneous oncology. His clinical focus is centered on the diagnosis and treatment of cutaneous lymphoma, lymphomatoid disorders (skin conditions that resemble lymphoma), melanoma and non-melanoma skin cancers and has directed the Multidisciplinary Cutaneous Lymphoma program at the Huntsman Cancer Institute since 2012. He has been involved in multiple clinical trials associated with the treatment of cutaneous malignancies at the Huntsman Cancer Institute. He is board-certified in dermatology, dermatopathology, and anatomic and clinical pathology and is also the director of the Dermatopathology Laboratory at the University of Utah. As a practicing dermatopathologist, Dr. Wada also specializes in the interpretation of skin biopsies to help ensure that an accurate diagnosis of skin cancer is obtained and he has a particular interest in the pathology of skin lymphoma and related diseases.

Board Certification

American Board of Dermatology
National Board of Medical Examiners
American Board of Pathology (Clinical Path)
American Board of Pathology (Sub: Dermatopathology)
American Board of Pathology (Sub: Anatomic Path)

Patient Rating

Patients consistently praise Dr. Wada and his team for their expertise, thoroughness, and clear explanations of diagnosis and treatment options. Many comment on compassionate bedside manner, attentive listening, and feeling respected and included in decision-making rather than rushed. The care team is frequently described as responsive, professional, and supportive, leaving patients feeling confident and well cared for.

Generated via Patient Reviews

5.0 /5
( out of 36 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Feb 16, 2026
HUNTSMAN CANCER CENTER

Was not rushed during the visit. Listened to me. Outlined the next steps.

Feb 08, 2026
HUNTSMAN CANCER CENTER

Dr. David Wada is an excellent physician. He is very professional and personable, blending high quality care with high personal connection. His expertise is top notch, but he also understands the art of the healer and the importance of making a strong personal connection.

Oct 11, 2025
HUNTSMAN CANCER CENTER

Great Dr and team!

Oct 06, 2025
HUNTSMAN CANCER CENTER

Dr. Wada and his staff are excellent to work with. He listens, is friendly and kind, and partners with me in determining my care. Highly recommended!!

Oct 04, 2025
HUNTSMAN CANCER CENTER

Dr. David Wada is extremely knowledgeable about MF. My condition has been improved tremendously under his care.

May 04, 2025
HUNTSMAN CANCER CENTER

Dr. Wada and his team really care about his patients. They get back to you quickly when you call with questions. Dr. Wada and his team make sure that you understand your cancer and its treatment options and that you are a part of the decision making process. Dr. Wada is an excellent doctor.

Apr 12, 2025
HUNTSMAN CANCER CENTER

We love Dr. Wada. He is the best. Even though he is always busy, he will spend the time you need and makes you feel as the most important person. He will spend the time you need to get questions answered. Thank you Dr. Wada.

Apr 12, 2025
HUNTSMAN CANCER CENTER

Dr Wada is the best. Thank You for caring about me and my wife. Take a vacation, you deserve it.

Feb 08, 2025
HUNTSMAN CANCER CENTER

Very professional. Very nice. A good carring person

Dec 08, 2024
HUNTSMAN CANCER CENTER

I know he cares and spends time in talking to you about anything concerning the issue at hand.

Nov 11, 2024
HUNTSMAN CANCER CENTER

Dr. Wada was very kind, professional, knowledgeable, empathetic, and compassionate to make sure I understood my disease, options and the plan moving forward. I HIGHLY recommend him!!!!!

Oct 29, 2024
HUNTSMAN CANCER CENTER

Doctor Wada and his team is the best in the class. Much appreciated their help.

Oct 21, 2024
HUNTSMAN CANCER CENTER

Dr Wada is a gem. I have a rare form of cancer - T cell lymphoma- that shows up in the skin. Dr Wada and Dr Bowling knew exactly what to look for and were as caring and patient as anyone could ask for. The nurse and EMT on the team rounded out a caring group. I may die of this but I know my team will do everything possible me to get me well or at least managed. They are super positive and it was weird to laugh HARD while biopsy procedures were being done. I felt hope for the first time since my mysterious diagnosis for the past 8 weeks. Bless you.

Sep 14, 2024
HUNTSMAN CANCER CENTER

Dr Wada was very professional, knowledgeable, kind and reassuring.

Sep 03, 2024
HUNTSMAN CANCER CENTER

Dr. Wada has consistently been incredibly personable, knowledgeable and shown empathy for my condition.

Jul 20, 2024
HUNTSMAN CANCER CENTER

Good bedside manner

Jun 08, 2024
HUNTSMAN CANCER CENTER

Dr. Wada is very knowledgeable, caring and has always treated us with very well.

Mar 27, 2024
HUNTSMAN CANCER CENTER

Hook Dr. Wada up with a John Deere Gator

Mar 24, 2024
HUNTSMAN CANCER CENTER

Excellent and caring physician

Feb 17, 2024
HUNTSMAN CANCER CENTER

Very professional in explaining my diagnosis.

Jan 13, 2024
HUNTSMAN CANCER CENTER

HE IS UNSURPASSED AS A PHYSICIAN AND AS A COMPASSIONATE CARE GIVER. I seen many ¿. He is absolutely wonderful.

Jan 06, 2024
HUNTSMAN CANCER CENTER

Thank you so much for everything! I feel so much better knowing your team is taking care of me.

Nov 26, 2023
HUNTSMAN CANCER CENTER

Dr. Wada is very respectful and informative.

Nov 18, 2023
HUNTSMAN CANCER CENTER

Exceptional experience with Dr. Wada! I feel incredibly confident in the care I'm receiving for my MF'I know I'm in excellent hands.

Nov 04, 2023
HUNTSMAN CANCER CENTER

As mentioned in the previous commentary, we feel fortunate to be under the care of Dr. Wada and his team - he is clearly an expert in this field and has an incredible team that he has worked with over the years - he was very patient in explaining the disease and all of the possible methods of treatment - we were actually surprised that he spent as much time with us as he did - we feel that we could not be in better care and that we are incredibly fortunate to have been referred to Dr. Wada and his team and to have garnered an appointment in such a reasonable period of time

Oct 28, 2023
HUNTSMAN CANCER CENTER

Dr. Wada is an excellent physician with a great deal of knowledge, compassion, and care. He listens a d takes time to answer questions. I never feel rushed or that anything I ask is too minor. I am pleased with my care.

Oct 22, 2023
HUNTSMAN CANCER CENTER

Amazing doctor

Oct 01, 2023
HUNTSMAN CANCER CENTER

Experienced, straight forward, kind, and explaining options

Aug 12, 2023
HUNTSMAN CANCER CENTER

Dr. Wada is very thorough, professional, and friendly. I trust his care.

Aug 06, 2023
HUNTSMAN CANCER CENTER

An excellent doctor. He is knowledgeable and caring. His team is excellent and extremely helpful.

Jul 03, 2023
HUNTSMAN CANCER CENTER

Ive had good physicians in the past, but Dr Wada seems to be a cut above. Hes compassionate about my condition, shows that he cares, explains things in a way that I can understand, and most importantly I didnt feel rushed.

May 27, 2023
HUNTSMAN CANCER CENTER

A++

May 13, 2023
HUNTSMAN CANCER CENTER

I am very comfortable with his care

May 07, 2023
HUNTSMAN CANCER CENTER

Took time to listen.

Mar 25, 2023
HUNTSMAN CANCER CENTER

Dr. Wada always treats me very good.

Mar 11, 2023
HUNTSMAN CANCER CENTER

Se ve que es una persona muy seria y muy dedicada a su profesin

Mar 08, 2023
HUNTSMAN CANCER CENTER

A very good MD

Feb 18, 2023
HUNTSMAN CANCER CENTER

Great bed side manner

Feb 12, 2023
HUNTSMAN CANCER CENTER

Dr. Wada is an exception doctor who takes great effort to render the exact care I need for my condition. He is thorough, caring, and has a wonderful sense of humor. He is excellent at answering any questions and provides a full explanation of my condition with appropriate treatment. The BEST!

Feb 11, 2023
HUNTSMAN CANCER CENTER

Very personable. Explains everything very well.

Feb 11, 2023
HUNTSMAN CANCER CENTER

In my last visit, Dr Wada recognized that the cancer is now progressed to where I am terminal. He showed sign of compassion but had a hard time in explaining my case and long longgevit for the next while and wanted to refer me to an oncologist to explain my life. He covered up the skin biopsy to where I have to wait even though I already know th results. I guess to stall my pain.

Feb 04, 2023
HUNTSMAN CANCER CENTER

Very compassionate and professional. He explained the condition enough for me to understand.

Jan 31, 2023
HUNTSMAN CANCER CENTER

Understands my problem and has knowledge of treatments I didn't know existed. I trust him.

Jan 30, 2023
HUNTSMAN CANCER CENTER

Dr. Wada is terrific. Such a caring and professional person!

Dec 19, 2022
HUNTSMAN CANCER CENTER

He's the best in all respects!

Dec 11, 2022
HUNTSMAN CANCER CENTER

He asked me questions about my thoughts - recognized and respected my body. He was a partner in my care and it mattered.

Dec 05, 2022
HUNTSMAN CANCER CENTER

Top of the line

Sep 18, 2022
HUNTSMAN CANCER CENTER

All excellent

Sep 09, 2022
HUNTSMAN CANCER CENTER

Dr. Wadda, Mary Ann, and the staff are great and caring. They are the best.

Aug 28, 2022
HUNTSMAN CANCER CENTER

Explained condition and options in understandable terms, polite and caring

Aug 02, 2022
HUNTSMAN CANCER CENTER

Good

Jul 17, 2022
HUNTSMAN CANCER CENTER

Dr. David Wada is the finest Oncological Dermatologist of which I'm aware.

Jul 05, 2022
HUNTSMAN CANCER CENTER

Dr. Wada and his staff have excellent bedside manner. The communication was clear and caring.

May 10, 2022
HUNTSMAN CANCER CENTER

Good

Apr 25, 2022
HUNTSMAN CANCER CENTER

We are in the hands of God and his A Team of angels

Apr 10, 2022
HUNTSMAN CANCER CENTER

Highly recommend!

Apr 03, 2022
HUNTSMAN CANCER CENTER

I have been seeing Dr. Wada for some time. I am very confident in his care. Listens to me. Very compassionate and caring. I feel great after completing my appointment because I know I have the best of care.

Mar 14, 2022
HUNTSMAN CANCER CENTER

Dr. Wada and his staff are the best!

Mar 13, 2022
HUNTSMAN CANCER CENTER

Very professional and informational

Feb 25, 2022
HUNTSMAN CANCER CENTER

Dr Wada and Maryanne take the time to be thorough and check everything they need to, and they are kind and gentle and respectful of my person. I feel safe with them. They are very concerned about my well-being, help me understand what I need to do for my care, and teach me about my condition. They celebrate with me when things go well. On my first appointment I was scared and confused, but this time I felt more confident about understanding my condition because of their help. Maryanne asks about fun things in my life and allows me to share. I am so thankful for them!

Feb 22, 2022
HUNTSMAN CANCER CENTER

The entire Wada team is exceptional regarding my care, discussion of questions and issues (if any) and they make my visit highly enjoyable!!! KUDO's to ALL!!!

Feb 20, 2022
HUNTSMAN CANCER CENTER

Very knowledgeable and courteous.

Feb 01, 2022
HUNTSMAN CANCER CENTER

Dr. Wada is the BEST there is!!!

Feb 01, 2022
HUNTSMAN CANCER CENTER

Dr. Wada is terrific. We really appreciate his professionalism and positive manner!

Jan 17, 2022
HUNTSMAN CANCER CENTER

They are Awesome!

Jan 09, 2022
HUNTSMAN CANCER CENTER

Our overall feeling, besides relief, was that our daughter has been delivered into the Big Hands of God and his Super God Team. We could not ask for a more capable, skilled, compassionate, or professional care provider than Dr. Wada and his team. They function like a highly tuned, precision machine, but with kid gloves.

Dec 13, 2021
HUNTSMAN CANCER CENTER

The whole team was amazing to work with.

Nov 09, 2021
HUNTSMAN CANCER CENTER

Excellent experience - Dr. Wada and his team!

Nov 08, 2021
HUNTSMAN CANCER CENTER

Fantastic

Oct 26, 2021
HUNTSMAN CANCER CENTER

Very thorough and caring.

Sep 22, 2021
HUNTSMAN CANCER CENTER

I was extremely pleased with my visit with Dr. Wada. Outstanding care.

Aug 23, 2021
HUNTSMAN CANCER CENTER

I do highly recommend Dr. David Wada, Dermatology and Maryanne Bowling, Nurse Practitioner to everyone with Dermatology Cancer issues. This team is the greatest in the Huntsman Cancer Institute.

Aug 23, 2021
HUNTSMAN CANCER CENTER

Good

Jul 18, 2021
HUNTSMAN CANCER CENTER

They were all professional, friendly and efficient

Jun 27, 2021
HUNTSMAN CANCER CENTER

OMG!! Dr Wada, Marianne, Andy, and the team are amazing!! always so personable and interested in any concerns I have, and then we get to chat and catch up until the next year - I just LOVE you all!!

Jun 27, 2021
HUNTSMAN CANCER CENTER

I feel like all the care providers were very friendly and competent

Jun 14, 2021
HUNTSMAN CANCER CENTER

Dr Wada and Team are exceptional. Truly Exceptional. Their approach to the exam and explanations are outstanding

Apr 28, 2021
HUNTSMAN CANCER CENTER

Excellent care, can't be treated any better.

Apr 25, 2021
HUNTSMAN CANCER CENTER

Exceptional patient care & caring attitude!

Mar 21, 2021
HUNTSMAN CANCER CENTER

Awesome

Mar 15, 2021
HUNTSMAN CANCER CENTER

As always everyone did a fantastic job. I always feel like I'm a part of the team rather than apart from them. There are very few if any doctor visits I look forward to...this one is the exception for sure. I can't say enough good things about my team - they are the best!

Mar 15, 2021
HUNTSMAN CANCER CENTER

the physician and nurse practitioner were excellent.

Mar 14, 2021
HUNTSMAN CANCER CENTER

My providers always listen to my concerns.

Mar 07, 2021
HUNTSMAN CANCER CENTER

Been with Dr. Wada for 7 years and his NP is the same, the Nurse and assistant have been there for multiple years. Makes me feel at ease and nice that we are all on the same page.

Feb 26, 2021
HUNTSMAN CANCER CENTER

Very caring, open to questions, always has the answer. I feel like my well being is his priority.

Feb 03, 2021
HUNTSMAN CANCER CENTER

Dr. Wada acted immediately on my concerns.

Dec 20, 2020
HUNTSMAN CANCER CENTER

appreciate very much the care I have received

Dec 14, 2020
HUNTSMAN CANCER CENTER

expectations were very high and results were above expectations

Nov 24, 2020
HUNTSMAN CANCER CENTER

Dr. Wada was exceptional

Nov 23, 2020
HUNTSMAN CANCER CENTER

Dr. Wada and Mary Ann Bowling very knowledgeable, professional and have great communication skills. My interaction with this team is always entertaining.

Nov 08, 2020
HUNTSMAN CANCER CENTER

Dr Wada always explains to me what the problem is and the best way to treat it. It is the best

Oct 25, 2020
HUNTSMAN CANCER CENTER

very responsive to my needs

Sep 22, 2020
HUNTSMAN CANCER CENTER

As with previous visits, Dr. Wada is thorough, caring, thoughtful and takes the time needed to answer all your questions.

Sep 11, 2020
HUNTSMAN CANCER CENTER

Dr. Wadda and his staff are great.

Sep 10, 2020
HUNTSMAN CANCER CENTER

He treated _____ with respect and spoke to her directly, which doesn't always happen with someone with disabilities in a medical office. He took the time needed to address her concerns in a kind and gentle way . She feels part of her treatment team because he has included her.

Aug 25, 2020
HUNTSMAN CANCER CENTER

Good experience, the doctor and his team were very professional. They were helpful in explaining all of my questions.

Aug 19, 2020
HUNTSMAN CANCER CENTER

talked with me in language i could understand and responded to my questions

Aug 11, 2020
HUNTSMAN CANCER CENTER

Marianne and Dr wada were amazing

Jul 20, 2020
HUNTSMAN CANCER CENTER

Dr. Wada (and staff) were amazing!!! Thorogh exam & explanation was truly appreciated. My wife attended via phone and both of us found that Dr. Wada was very attentive and interactive with our questions & discussions of my condition and care options! Very appreciative! zFelt like I was important & worthy of his time!

Jul 07, 2020
HUNTSMAN CANCER CENTER

I appreciate the teams help.

Jul 06, 2020
HUNTSMAN CANCER CENTER

excellent

May 01, 2020
HUNTSMAN CANCER CENTER

excellent experience

Mar 14, 2020
HUNTSMAN CANCER CENTER

Exceptional as always. Everyone, and I mean everyone is always very informative, concerned and friendly. Its a rare thing I believe when someone looks forward to seeing their doctor. While I have my health issues that Im concerned about everyone does a great job helping me understand and feeling cared for. Great work!

Mar 12, 2020
HUNTSMAN CANCER CENTER

Im glad about this service.

Mar 09, 2020
HUNTSMAN CANCER CENTER

Dr. Wada and his staff were extremely kind and made me feel very comfortable

Feb 24, 2020
HUNTSMAN CANCER CENTER

rxcellant

Feb 24, 2020
HUNTSMAN CANCER CENTER

good

Feb 20, 2020
HUNTSMAN CANCER CENTER

Dr. Wada and his team shows care, kindness to my concerns. Thank you

Feb 10, 2020
HUNTSMAN CANCER CENTER

Dr WADA, Maryann, Nick & Julie are FABULOUS and show great concern & care for my well-being. They are wonderful to work with & I am so happy they are part of my health care team!!

Feb 06, 2020
HUNTSMAN CANCER CENTER

Everything was handled very professionally!


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

David Wada, MD is a dermatologist who specializes in cutaneous oncology. His clinical focus is centered on the diagnosis and treatment of cutaneous lymphoma, lymphomatoid disorders (skin conditions that resemble lymphoma), melanoma and non-melanoma skin cancers and has directed the Multidisciplinary Cutaneous Lymphoma program at the Huntsman Cancer Institute since 2012. He has been involved in multiple clinical trials associated with the treatment of cutaneous malignancies at the Huntsman Cancer Institute. He is board-certified in dermatology, dermatopathology, and anatomic and clinical pathology and is also the director of the Dermatopathology Laboratory at the University of Utah. As a practicing dermatopathologist, Dr. Wada also specializes in the interpretation of skin biopsies to help ensure that an accurate diagnosis of skin cancer is obtained and he has a particular interest in the pathology of skin lymphoma and related diseases.

Board Certification and Academic Information

Academic Departments Dermatology -Associate Professor (Clinical)
Board Certification
American Board of Dermatology
National Board of Medical Examiners
American Board of Pathology (Clinical Path)
American Board of Pathology (Sub: Dermatopathology)
American Board of Pathology (Sub: Anatomic Path)

Education history

Undergraduate Biology, with Distinction - University of Hawaii B.A.
Graduate Training Biomedical Sciences, Cell, Molecular, & Neuroscience Interdisciplinary Program - University of Hawaii M.S.
Professional Medical Medicine - University of Hawaii School of Medicine M.D.
Internship Internal Medicine - Exempla St. Joseph¿s Hospital Intern
Residency Anatomic and Clinical Pathology - University of Utah Health Sciences Center Resident
Fellowship Dermatopathology - Mayo Clinic Fellow
Fellowship Dermatology - Mayo Clinic Fellow
Residency Dermatology - Mayo Clinic Resident

Selected Publications

Journal Article

  1. Khalighi MA, Snook JP, Cocks MM, Leiferman KM, Wada DA, Zone J (2026). Diffuse Dermal Immunoglobulin Deposition and Monoclonal Gammopathy. JAMA dermatology,
  2. Siebenhaar F, Broesby-Olsen S, Castells M, George TI, Livideanu CB, Álvarez-Twose I, Panse J, Barete S, Reiter A, Dybedal I, Akin C, Van Daele P, Radia DH, Cerquozzi S, Ustun C, Sabato V, Gotlib J, Rafferty M, DeAngelo DJ, Schafhausen P, Ungerstedt J, Ogbogu PU, Florell S, Wada DA, Rets A, Lin HM, Bidollari I, Hong J, Shaheen D, Lampson B, Hartmann (2026). Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study. Journal of the American Academy of Dermatology,
  3. Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas (2026). Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial. Nature cancer, 7(2), 272-282.
  4. Orton CJ, Hopkins ZH, Trump B, Kroes A, Lebiedz-Odrobina D, Clardy SL, Florell A, Bowen AR, Duffy K, Wada DA, Florell S (2025). Assessing Real-World Utilization/Performance of Salivary Gland Biopsy in Diagnosis of Sjögren Disease: Impact of Overweighting Without Objective Glandular Testing. Journal of clinical rheumatology, 32(1), 32-35.
  5. Hieken TJ, Egger ME, Angeles CV, Hyngstrom JR, Burke EE, Lowe MC, Beasley GM, Bartlett EK, Bresler SC, Harms KL, Zager JS, Lehman JS, Wasif N, Bagaria SP, McMasters KM, Wada DA, Pandalai P, Delman KA, Lee J, Busam KJ, Messina JL, Sondak V (2025). Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 Study. JAMA surgery,
  6. Howell JN, Mark B, Wada DA, Bowling M, Wei M, Lloyd SL, Gaffney DK, Maity A, LaRiviere MJ, Rule WG, Grant JD, Deshmukh V, Newman M, Date A, Hashibe M, Tao (2025). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer medicine, 14(5), e70577.
  7. Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, Sosman JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Khushalani NI, Markowitz J, Negrea G, Kasbari S, Doolittle GC, Swami U, Roberts T, Mathew BN, Medina E, Baselga-Carretero I, Gonzalez CR, Garcilazo IP, Vega-Crespo A, Chen JM, Naser Al-Deen N, Patel SP, Sharon E, Moon J, Wu MC, Ribas (2025). Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. Nature medicine,
  8. Howell J, Mark B, Wada DA, Bowling M, Wei M, Lloyd S, Gaffney D, Maity A, LaRiviere M, Rule W, Deshmukh V, Newman M, Hashib D (2025). Mental Health Outcomes in Patients with Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer medicine, 14(5), e70577.
  9. Kasera S,Weil CR,Wada D,Bowling M,Hu B,Gaffney DK,Maity A,Tao (2024). Ultra-low dose radiation therapy for primary cutaneous indolent B-cell lymphomas. JEADV clinical practice, 3(4), 1190-1194.
  10. Broadbent E,Spivak AM,Kartes J,Lawyer P,Wada DA,Zussman J,Schmidt (2024). Persistent, sterile necrotizing granulomatous dermatitis following treatment of 20-year Mycobacterium marinum infection. JAAD case reports, 53, 86-89.
  11. Broadbent E, Spivak AM, Kartes J, Lawyer P, Wada DA, Zussman J, Schmidt (2024). Persistent, sterile necrotizing granulomatous dermatitis following treatment of 20-year Mycobacterium marinum infection. JAAD case reports, 53, 86-89.
  12. Ufkes NA, Tao R, Halwani AS, Miles R, Cipriano SD, Bowling M, Florell S, Gaffney D, Wada D (2024). Clinical spectrum of indolent mycosis fungoides with gamma-delta ¿/¿ phenotype: a single institution review including therapy and outcomes. JEADV clinical practice,
  13. Elkeeb DM, Hopkins ZH, Bolender CM, Moreno C, Florell SR, Bowen AR, Vitale P, Zussman J, Duffy K, Grossman D, Secrest AM, Wada D (2023). A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management. The American Journal of dermatopathology, 45(1), 28-39.
  14. Abbott J, Corean J, Snyder AM, Florell SR, Miles R, Stephens D, Wada D (2023). Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions. Skin health and disease, 3(3), e208.
  15. Brunsgaard EK, Bowles TL, Asare EA, Grossmann K, Boucher KM, Grossmann A, Jackson JA, Wada DA, Rathore R, Budde G, Grandemange A, Hyngstrom J (2023). Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Melanoma research, 33(3), 184-191.
  16. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan L (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Challenge. The American Journal of dermatopathology, 45(5), e32-e34.
  17. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan L (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Answer. The American Journal of dermatopathology, 45(5), 344-345.
  18. Kuceki G,Nguyen C,Ng D,Wada D,Mathis (2023). Oral diffuse large B-cell lymphoma presenting as a bland nodule. JAAD case reports, 36, 34-37.
  19. Abbott J,Corean J,Snyder AM,Florell SR,Miles R,Stephens D,Wada D (2023). Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions. JAAD case reports, 3(3),
  20. Orlow I,Sadeghi KD,Edmiston SN,Kenney JM,Lezcano C,Wilmott JS,Cust AE,Scolyer RA,Mann GJ,Lee TK,Burke H,Jakrot V,Shang P,Ferguson PM,Boyce TW,Ko JS,Ngo P,Funchain P,Rees JR,O'Connell K,Hao H,Parrish E,Conway K,Googe PB,Ollila DW,Moschos SJ,Hernando E,Hanniford D,Argibay D,Amos CI,Lee JE,Osman I,Luo L,Kuan PF,Aurora A,Rothberg BEG,Bosenberg MW,Gerstenblith MR,Thompson C,Bogner PN,Gorlov IP,Holmen SL,Brunsgaard EK,Saenger YM,Shen R,Seshan V,Nagore E,Ernstoff MS,Busam KJ,Begg CB,Thomas NE,Berwick M,Reynolds AZ,Corcoran D,Gong W,Vondras A,Lin L,Arora A,Kostrzewa CE,Ilelaboye GE,Parmar H,Leong S,Corrales S,Moran U,Heguy A,Ramaswami S,Zhu D,Fang S,Yan S,Panse G,Fullerton BT,Colman H,Wada D,Manrique-Silva E,Requena C,Traves V,Millan-Esteban D,Rainka M,Huberman K,Dunigan M,Viale A,Mohibullah N,Socci N,Rizzatti A,Cohen B,Bayuga S,Weil (2023). InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PloS one, 18(4 April),
  21. Grant GJ,Sahni DR,Florell AJ,Hull CM,Florell SR,Miles RR,Wada DA,Bowen A (2023). An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin. PloS one, 34, 86-89.
  22. Grant GJ, Sahni DR, Florell AJ, Hull CM, Florell SR, Miles RR, Wada DA, Bowen A (2023). An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin. JAAD case reports, 34, 86-89.
  23. Kuceki G, Nguyen C, Ng D, Wada D, Mathis (2023). Oral diffuse large B-cell lymphoma presenting as a bland nodule. JAAD case reports, 36, 34-37.
  24. Maurer M, Siebenhaar F, Boresby-Olsen S, George T, Livideanu CB, Alvarez-Twose I, Panse J, Barete S, Reiter A, Dybedal I, Akin C, Van Daele P, Radia D, Cerquozzi S, Ustun C, Sabato V, Gotlib J, Rafferty M, DeAngelo D, Ogbogu P, Florell S, Wada D, Rets A, Lin HM, Hong J, Green T, Scherber R, Roche M, Castells M, Hartmann (2023). Avapritinib Improved Skin Findings in Patients with Indolent Systemic Mastocytosis (ISM) in the Registrational, Double-Blind, Placebo Controlled PIONEER Study. . The Journal of allergy and clinical immunology, 151(2 Supplement), AB340.
  25. Brunsgaard EK, Bowles TL, Asare EA, Grossmann K, Boucher KB, Grossmann A, Jackson JA, Wada DA, Rathore R, Budde G, Grandemange A, Hyngstrom J (2023). Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Melanoma research, 33(3), 184-191.
  26. Grant GJ, Wada DA, Madigan L (2022). Erythematous papules and umbilicated pustules on a man with proctitis. International journal of dermatology,
  27. Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney D (2022). Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leukemia & lymphoma, 63(10), 2428-2435.
  28. Abbott J, Corean J, Laggis C, Halwani A, Toydemir R, Miles R, Florell S, Wada (2022). Histological Transformation and Clonal Relationship of Subcutaneous Marginal Zone B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma. The American Journal of dermatopathology, 44(6), 442-448.
  29. Abbott J,Westerdahl JS,Wada D,Klein S,Mathis (2022). Paraneoplastic subacute cutaneous lupus erythematosus with mucositis. PloS one, 22, 38-41.
  30. Abbott J, Westerdahl JS, Wada D, Klein S, Mathis (2022). Paraneoplastic subacute cutaneous lupus erythematosus with mucositis. JAAD case reports, 22, 38-41.
  31. Stephens D, Atkinson A, Abbot J, Bowling M, Williams J, Pomicter T, Fitzgerald L, Wada (2022). High Prevalence of Beta-Human Papilloma Virus in Patients wtih Concurrent Chronic Lymphocytic Leukemia and Non-Melanoma Skin Cancer. Blood, 140(Supplement 1), 7053.
  32. Flores S, Wada DA, Florell SR, Bowen AR (2020). Pretibial Pruritic Papular Dermatitis: A Comprehensive Clinical and Pathologic Review of Cases at a Single Institution. Am J Dermatopathol, 42(1), 16-19.
  33. Laggis C, Wada D, Shah A, Zussman J (2020). Eosinophils are surprisingly common in biopsy specimens of cutaneous herpes simplex virus and varicella zoster virus infections: Results of a comprehensive histopathologic and clinical appraisal. J Cutan Pathol, 47(1), 6-11.
  34. C.W. Laggis A. Lamb A.M. Secrest N. Ufkes A.S. Halwani R. Tao D. Gaffney R.R. Miles S.R. Florell D. Wada (2020). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. J Eur Acad Dermatol Venereol.
  35. Oishi N, Sartori-Valinotti JC, Bennani NN, Wada DA, He R, Cappel MA, Feldman AL (2019). Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features. J Cutan Pathol, 46, 637-644.
  36. Clark JJ, Hawkes JE, Florell SR, Miles RR, Wada DA (2019). Cutaneous T-Cell Acute Lymphoblastic Leukemia and the Expression Pattern of Terminal Deoxynucleotidyl Transferase Immunostaining in Mycosis Fungoides and Spongiotic Dermatitis. Dermatopathology (Basel), 6(3), 182-188.
  37. Cowan N,Coman G,Duffy K,Wada D (2019). Treatment of recalcitrant mycosis fungoides with topical gentian violet. PloS one, 5(5), 413-415.
  38. Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA (2018). Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). J Am Acad Dermatol, 79(2), 238-244.
  39. Elkeeb D, Hopkins Z, Miles RR, Halwani A, Wada D (2018). Ominous cutaneous presentation of acute myeloid leukemia without peripheral blood involvement upon initial presentation and relapse: case report and literature review. Eur J Dermatol, 28(6), 809-817.
  40. Elkeeb D,Hopkins Z,Wada D,Rhoads JL (2018). A case of primary cutaneous malakoplakia in a cardiac transplant recipient. PloS one, 4(10), 982-984.
  41. Gardner LJ, Ward M, Andtbacka RHI, Boucher KM, Bowen GM, Bowles TL, Cohen AL, Grossmann K, Hitchcock YJ, Holmen SL, Hyngstrom J, Khong H, McMahon M, Monroe MM, Ross CB, Suneja G, Wada D, Grossman D (2017). Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis. Melanoma Res, 27(5), 477-484.
  42. Clark JJ, Bowen AR, Bowen GM, Hyngstrom JR, Hadley ML, Duffy K, Florell SR, Wada DA (2017). Cutaneous carcinosarcoma: a series of six cases and a review of the literature. J Cutan Pathol, 44(1), 34-44.
  43. Donigan JM, Collins ZN, Wada DA (2017). Eruption of Yellow-Brown and Red-Brown Papules in a Young Adult With Polydipsia and Polyuria. JAMA Dermatol, 153(8), 813-814.
  44. Florell AJ,Wada DA,Hawkes J (2017). Linear focal elastosis associated with exercise. PloS one, 3(1), 39-41.
  45. Shon W, Wada DA, Kalaaji AN (2016). Radiation-induced pemphigus or pemphigoid disease in 3 patients with distinct underlying malignancies. Cutis, 97(3), 219-22.
  46. Liaqat M, Wilson LH, Wada D, Florell SR, Bowen AR (2015). Neutrophilic sebaceous adenitis with intralobular Demodex mites: a case report and review of the literature. Am J Dermatopathol, 37(4), 315-8.
  47. Hawkes JE, Florell SR, Wada DA (2015). Chronic, Painful, Nonhealing Ulcer on the Right Arm Following Minor Trauma. JAMA Dermatol, 151(7), 787-8.
  48. Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA (2014). GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood, 123(19), 3007-15.
  49. Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, Gibson LE (2014). Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J Am Acad Dermatol, 70(6), 1021-7.
  50. A.E. Wagner D. Wada G. Bowen D.K. Gaffney (2013). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. Br J Dermatol.
  51. Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE (2013). Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol, 69(4), 557-64.
  52. Wada DA, Pittelkow MR, Comfere NI, Gibson LE, Ansell SM, Wilcox RA (2013). CD4(+)CD25(+)FOXP3(+) malignant T cells in Sezary syndrome are not necessarily functional regulatory T cells. J Am Acad Dermatol, 69(3), 485-9.
  53. Podjasek JO, Wetter DA, Pittelkow MR, Wada DA (2012). Henoch-Schonlein purpura associated with solid-organ malignancies: three case reports and a literature review. Acta Derm Venereol, 92(4), 388-92.
  54. Podjasek JO, Wetter DA, Pittelkow MR, Wada DA (2012). Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009. J Am Acad Dermatol, 66(2), e55-65.
  55. de Souza A, el-Azhary RA, Camilleri MJ, Wada DA, Appert DL, Gibson LE (2012). In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol, 66(6), 928-37.
  56. Hocker TL, Wada DA, El-Azhary R, Gibson LE (2012). Expression of T-cell receptor-gammadelta in normal human skin, inflammatory dermatoses and mycosis fungoides. J Cutan Pathol, 39(4), 419-24.
  57. de Souza A, Sokumbi O, Wada DA, el-Azhary RA (2012). Chemokine responses in palladium-induced lichenoid eruption: similarities to and differences from lichen planus. Dermatitis, 23(4), 180-1.
  58. Wada DA, Wilcox RA, Harrington SM, Kwon ED, Ansell SM, Comfere NI (2011). Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sezary syndrome. Am J Hematol, 86(3), 325-7.
  59. Hendi A, Wada DA, Jacobs MA, Crook JE, Kortuem KR, Weed BR, Otley CC, Gibson LE (2011). Melanocytes in nonlesional sun-exposed skin: a multicenter comparative study. J Am Acad Dermatol, 65(6), 1186-93.
  60. Shon W, Wada DA, Gibson LE, Flotte TJ, Scheithauer BW (2011). Distinctive eosinophilic cytoplasmic inclusion bodies in melanocytic nevi: an immunohistochemical and ultrastructural study. J Cutan Pathol, 38(11), 865-70.
  61. Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza Ad, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL (2011). Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol, 24(4), 596-605.
  62. Wada DA, Wilcox RA, Weenig RH, Gibson LE (2010). Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis. J Cutan Pathol, 37(5), 535-41.
  63. Wilcox RA, Feldman AL, Wada DA, Yang ZZ, Comfere NI, Dong H, Kwon ED, Novak AJ, Markovic SN, Pittelkow MR, Witzig TE, Ansell SM (2009). B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood, 114(10), 2149-58.
  64. Wilcox RA, Wada DA, Ziesmer SC, Elsawa SF, Comfere NI, Dietz AB, Novak AJ, Witzig TE, Feldman AL, Pittelkow MR, Ansell SM (2009). Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood, 114(14), 2936-44.
  65. de Souza A, Camilleri MJ, Wada DA, Appert DL, Gibson LE, el-Azhary RA (2009). Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients. J Am Acad Dermatol, 61(6), 993-1000.
  66. Wada DA, Perkins SL, Tripp S, Coffin CM, Florell SR (2007). Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare. Am J Clin Pathol, 127(2), 263-70.
  67. Wada DA, Szakacs J, Kennedy AM, Hafen BL, Opitz JM, Byrne JL (2004). Probable second fetus with Marles-Chudley syndrome: cardiac calcifications with ulnar deficiency and absent/hypoplastic thumbs. Fetal Pediatr Pathol, 23(2-3), 159-70.

Review

  1. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter M (2025). Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. American journal of clinical dermatology, 26(4), 499-510.
  2. Hodak E, Geskin L, Guenova E, Ortiz-Romero PL, Willemze R, Zheng J, Cowan R, Foss F, Mangas C, Querfeld (2022). Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. American journal of clinical dermatology, 24(1), 5-14.

Commentary

  1. Wada D (2022). A commentary on: Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma. PracticeUpdate,

Case Report

  1. Laggis C, Miles R, Stephens DM, Duffy K, Bowen A, Wada D (2019). Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report. J Cutan Pathol, 46(7), 538-541.
  2. Cowan N, Coman G, Duffy K, Wada DA (2019). Treatment of recalcitrant mycosis fungoides with topical gentian violet. JAAD Case Rep, 5(5), 413-415.
  3. Elkeeb D, Hopkins Z, Wada D, Rhoads JLW (2018). A case of primary cutaneous malakoplakia in a cardiac transplant recipient. JAAD Case Rep, 4(10), 982-984.
  4. Florell AJ, Wada DA, Hawkes JE (2017). Linear focal elastosis associated with exercise. JAAD Case Rep, 3(1), 39-41.
  5. R N Chavan 1, A G Bridges 1, R A Knudson 2, R P Ketterling 2, N Comfere 1, D A Wada 3, C Torres-Cabala 4, D J DiCaudo 5, G Vasmatzis 6, M R Pittelkow 5, A L Feldman 2 (2014). Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course. Blood Cancer J.
  6. Shon W, Wada DA, Folpe AL, Pittelkow MR (2012). Angiosarcoma in a patient with congenital nonhereditary lymphedema. Cutis, 90(5), 248-51.
  7. Hocker TL, Wada DA, McPhail ED, Porrata LF, el-Azhary RA, Gibson LE (2011). Relapsed hepatosplenic T-cell lymphoma heralded by a solitary skin nodule. J Cutan Pathol, 38(11), 899-904.
  8. Hocker TL, Wada DA, Bridges A, el-Azhary R (2010). Disseminated zygomycosis heralded by a subtle cutaneous finding. Dermatol Online J, 16(9), 3.
  9. de Souza A, Gibson LE, Wada DA, Yi ES, Medeiros F, Camilleri MJ, el-Azhary R, Micallef IN (2009). Resolution of CD8+ lymphomatoid papulosis after surgical excision of the type AB-thymoma. Am J Dermatopathol, 31(5), 475-9.
  10. Wada D, Morita M, Hardman JM (2004). January 2004: elderly Filipino man with frontal lobe tumor. Brain Pathol, 14(3), 337-8, 343.

Letter

  1. Laggis CW, Lamb A, Secrest AM, Ufkes N, Halwani AS, Tao R, Gaffney D, Miles RR, Florell SR, Wada D (2021). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(1), e42-e45.
  2. Lee K, Evans MG, Yang L, Ng S, Snowden C, Khodadoust M, Brown RA, Trum NA, Querfeld C, Doan LT, Song J, Zhang H, Gru AA, Wood GS, Wada DA, Shanmugam V, Haun PL, Aster JC, Duncan LM, Guitart J, Weinstock DM, Nardi V, Choi (2021). Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway. Blood, 138(23), 2435-2440.
  3. Hyde MA, Wada DA (2018). Patient education and support group for patients with cutaneous lymphoma and their caregivers. [Letter to the editor]. Clin Exp Dermatol, 44(1), 84-85.
  4. Wada C, Glenn MJ, Hyde M, Powell DL, Miles RR, Duffy K, Florell SR, Wada DA (2015). Primary cutaneous follicle centre lymphoma presenting as diffuse facial erythema. [Letter to the editor]. J Eur Acad Dermatol Venereol, 29(4), 825-6.
  5. Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D (2014). Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 71(4), 835-8.
  6. Chavan RN,Bridges AG,Knudson RA,Ketterling RP,Comfere N,Wada DA,Torres-Cabala C,Di Caudo DJ,Vasmatzis G,Pittelkow MR,Feldman A (2014). Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course. PloS one, 4(10),
  7. Wagner AE, Wada D, Bowen G, Gaffney DK (2013). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. [Letter to the editor]. Br J Dermatol, 169(3), 715-8.
  8. Wada DA, Agarwal N, Florell SR, Lim MS (2008). Recurrent squamous cell carcinoma and follicular lymphoma arising in the scalp after treatment for lymphoma. [Letter to the editor]. Pathology, 40(3), 316-20.

Abstract

  1. Kendra KL, Bellasea SI, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson W, Wada DA, Plaza JA, Sosman JA, In G, Ikeguchi AP, Hyngstrom J, Brohl A, Chmielowski B, Khushalani N, Markowitz J, Negrea G, Kasbari S, Doolittle GC, Swami U, Roberts T, Monroe M; Contreras C, Medina E, Baselga-Carretero I, Gonzalez CR, Perez Garcilazo I, Vega-Crespo A, Chen JM, Nasar Al-Deen N, Grossmann KF, Sondak V, Sharon E, Patel SP, Moon J, Wu MC, Ribas (2025). High melanoma-specific survival in patients with desmoplastic melanoma treated with single agent anti-PD-1 in SWOG S1512. 13(2_Supplement), PR006.

Other

  1. Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter M (2025). Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. American journal of clinical dermatology, 26(5), 851.
  2. Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, Sosman JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Khushalani NI, Markowitz J, Negrea G, Kasbari S, Doolittle GC, Swami U, Roberts T, Mathew BN, Medina E, Baselga-Carretero I, Gonzalez CR, Garcilazo IP, Vega-Crespo A, Chen JM, Naser Al-Deen N, Patel SP, Sharon E, Moon J, Wu MC, Ribas (2025). Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. Nature medicine,